Phase 3 trial assessing therapy for post-liver transplant HCV initiated – Healio
Phase 3 trial assessing therapy for post-liver transplant HCV initiatedHealioBiotest AG has initiated treatment in a phase 3 clinical trial in North America of a therapy for patients who require liver transplantation because of hepatitis C infection, a…
